| Name | GSK1702934A |
|---|
| Description | GSK1702934A is a selective TRPC3 agonist. GSK1702934A modulates cardiac contractility and f arrhythmogenesis by activation of TRPC3[1][2]. |
|---|---|
| Related Catalog | |
| Target |
TRPC3 |
| In Vitro | GSK1702934A is able to induce TRPC3/6-currents in HEK293 cells transduced with recombinant human TRPC3/6 with an EC50 of 0.08 mM and 0.44 mM, respectively[1]. GSK1702934A induces a transient, non-selective conductance and prolonged action potentials in TRPC3-overexpressing myocytes but not in wild-type myocytes[2]. GSK1702934A substantially promotes NCX currents in TRPC3-overexpressing myocytes[2]. |
| References |
| Molecular Formula | C22H25N3O2S |
|---|---|
| Molecular Weight | 395.52 |